This invention is directed to a method for treating a host infected with hepatitis B comprising administering an effective amount of an anti-HBV biologically active 2-deoxy--L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof, wherein the 2-deoxy--L-erythro-pentofuranonucleoside...http://www.google.fr/patents/US20030225028?utm_source=gb-gplus-shareBrevet US20030225028 - Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
